Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Vegf and Mmp-9 Gene Expression Caused by Treatment With Helicobacter Pylori Neutrophil-Activating Recombinant Protein in a Breast Cancer Model



Soleimani N1 ; Farhangi B2 ; Mohabati Mobarez A1 ; Etyabi F3 ; Hassan Saraf Z4
Authors

Source: Journal of Babol University of Medical Sciences Published:2015

Abstract

Background and objective: Breast cancer is a major cause of death in women, worldwide. Cytotoxic drugs may lead to various adverse side-effects in patients. Helicobacter pylori neutrophil-activating protein (HP-NAP) is one of the most important proteins, produced by helicobacter pylori. The purpose of this study was to investigate the expression of VEGF and MMP-9 genes, caused by HP-NAP treatment in a breast cancer model. Methods: In this experimental study, 18 female BALB/c mice, aged 6-8 weeks (19-23 g), were used. The mice were allocated to three groups: test group (treated with recombinant HP-NAP), positive control group (treated with an anti-cancer drug called trastuzumab), and negative control group (receiving phosphate-buffered saline). Expression and purification of HP-NAP were performed using nickel-resin affinity chromatography (Qiagen). The mice with breast tumors were treated with HP-NAP. MMP-9 and VEGF gene expression was measured using real-time polymerase chain reaction (PCR). Findings: Protein expression was confirmed, using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The analysis showed the expression of a 20, 000 dalton protein. Moreover, MMP-9 and VEGF gene expression decreased more significantly in the test group (due to treatment with HP-NAP), compared to the negative control group. The reduced expression in the test group was almost a quarter of the expression in the control group (p<0.01). Conclusion: The results showed that HP-NAP can reduce the expression of genes involved in metastasis in a mouse model of breast cancer. Therefore, this protein can be exploited for future therapeutic strategies in cancer treatment. © 2015, Babol University of Medical Sciences. All right reserved.
Related Docs
View other Related Docs
1. Evaluation of Nitric Oxide Production and Proliferation Activity of Recombinant Bacterioferritin of Helicobacter Pylori on Macrophages, Microbial Pathogenesis (2016)
2. Nanoparticle-Based Immunotherapy of Breast Cancer Using Recombinant Helicobacter Pylori Proteins, European Journal of Pharmaceutics and Biopharmaceutics (2020)
3. A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in Balb/C Mice, Open Life Sciences (2018)
Experts (# of related papers)
View all Related Experts
Abbas Bahador (3)
Naghmeh Bahrami (2)
Other Related Docs
4. Helicobacter Pylori Strains From Duodenal Ulcer Patients Exhibit Mixed Baba/B Genotypes With Low Levels of Baba Adhesin and Lewis B Binding, Digestive Diseases and Sciences (2016)
5. Canine Mammary Tumors As a Potential Model for Human Breast Cancer in Comparative Oncology, Veterinary Medicine International (2024)
6. Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein, International Journal of Hematology-Oncology and Stem Cell Research (2018)
7. Cloning, Expression and Purification of Hpaa Recombinant Protein of Helicobacter Pylori As a Vaccine Candidate, Journal of Pure and Applied Microbiology (2016)
8. Effects of Kojic Acid-Mediated Sonodynamic Therapy As a Matrix Metalloprotease-9 Inhibitor Against Oral Squamous Cell Carcinoma: A Bioinformatics Screening and in Vitro Analysis, Current Drug Discovery Technologies (2024)
9. The Evaluation of Wbp2nl-Related Genes Expression in Breast Cancer, Pathology and Oncology Research (2015)
10. Cloning, Expression, and Purification of Hpaa-Caga Fusion Recombinant Protein of Helicobacter Pylori in E. Coli Bl 21 Strain, Gene Reports (2019)
11. Insulin-Like Growth Factor 1 Serum Levels in Different Stages of Gastric Cancer and Their Association With Helicobacter Pylori Status, Peptides (2022)
12. Detection of Vascular Endothelial Growth Factor Messenger Rna (Vegf Mrna), Cytokeratin-19 Mrna (Ck19 Mrna), and Vascular Endothelial Growth Factor (Vegf) Protein Biomarker in the Peripheral Blood of Patients With Breast Cancer, Journal of Isfahan Medical School (2017)
13. Investigation of Molecular Mechanisms of S-1, Docetaxel and Cisplatin in Gastric Cancer With a History of Helicobacter Pylori Infection, Molecular Biotechnology (2024)
14. Association Between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients With Breast Cancer, International Journal of Preventive Medicine (2019)
15. Corrigendum] Antiproliferative Effects of Imatinib Mesylate on Zr‑75‑1 and Mda‑Mb‑231 Cell Lines Via Pdgfr‑Β, Pdgf‑Bb, C‑Kit and Scf Expression, International journal of molecular medicine (2019)
16. Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor As a Mouse Model of Triple-Negative Breast Cancer, Advanced Pharmaceutical Bulletin (2020)
17. Lactobacilli Modulate Hypoxia-Inducible Factor (Hif)-1 Regulatory Pathway in Triple Negative Breast Cancer Cell Line, Cell Journal (2016)